Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea

Abstract

The chronic disease management program (CDMP), a multilevel intervention including copayment reduction and physician incentives, was introduced in 2012 in Korea to improve blood pressure and glycemic control by strengthening the function of clinic as primary care institutions in managing hypertension and diabetes. This study, therefore, aimed to evaluate the effect of CDMP on the appropriateness of medication adherence and persistence in hypertension or type-2 diabetes patients.A pre-post retrospective study was conducted using claims cohort data from 2010 to 2013. Hypertension or type-2 diabetes patients were selected as the CDMP group, while dyslipidemia patients were the control group. Study groups were further categorized as clinic shifters or non-shifters on the basis of whether hospital use changed to clinic use during the study period. Prepost changes in adherence and persistence were assessed. Adherence was measured by medication possession ratio (MPR) and categorized as under (<0.8), appropriate (0.8-1.1), and over-adherence (>1.1). Persistence was measured by 12-month cumulative persistence rate.The pre-post change was significantly improved for appropriate-adherence (hypertension, +6.0%p; diabetes, +6.1%p), 12-month cumulative persistence (hypertension, +6.5%p; diabetes, +10.8%p), and over-adherence (hypertension, À5.3%p; diabetes, À2.8% p) only among the shifters in the CDMP group. Among these, patients visiting the same, single clinic showed a significant increase in appropriate-adherence, whereas those who changed their clinics showed a nonsignificant increase. No significant improvement was verified among the non-shifters in the CDMP group.CDMP improved medication adherence and persistence by significantly increasing appropriate-adherence and 12-month cumulative persistence rate in hypertension and type-2 diabetes patients. Particularly, CDMP significantly improved over-adherence, which was associated with increasing healthcare costs and hospitalization risk.Abbreviations: AHDs = antihypertensive drugs, BP = blood pressure, CDMP = chronic disease management program, COC = continuity of care, COCI = continuity of care index, CVD = cardiovascular disease, HbA1c = hemoglobin A1c, KNHIS-NSC = Korea National Health Insurance Service-National Sample Cohort, LLDs = lipid-lowering drugs, MPR = medication possession ratio, OADs = oral antidiabetes drugs, PDC = proportion of days covered, UPI = usual provider continuity index.

Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Romania

“…In Koreans, chronic disease management programs (DM and HTN) improved both the adherence and persistence of treatment. 31 In addition, Putnam et al, 32 in a practice-based survey on hypertensive patients with type 2 diabetes achieved the target BP in 54% of the cases, whereas patients with low adherence to therapy were less likely to achieve target BP levels.…”

The Impact of Treatment Adherence for Patients With Diabetes and Hypertension on Cardiovascular Disease Risk: Protocol for a Retrospective Cohort Study, 2008-2018

“…For example, previous research reported that mental health conditions (ie, depression, anxiety, and dementia) were important factors when analyzing treatment adherence and CVD events but lacked the ability to identify such mental conditions [73,74]. Many studies have used the Charlson Comorbidity Index [27-29] to explore the combined effects of comorbidities (ie, chronic obstructive pulmonary disease, depression, chronic kidney disease, and dementia), but this approach does not reflect the role of individual comorbidities. Furthermore, these studies did not control for duration of comorbidities.…”

Case management effectiveness for managing chronic illnesses in Korea: a systematic review

“…In Korea, chronic illnesses such as type 2 diabetes, hypertension and cardiovascular disease have led to increasing healthcare costs, especially because chronic illnesses are frequently comorbid diseases (Kim et al. , ; Shin et al. ).…”

“…In Korea, chronic illnesses such as type 2 diabetes, hypertension and cardiovascular disease have led to increasing healthcare costs, especially because chronic illnesses are frequently comorbid diseases (Kim et al 2014(Kim et al , 2017Shin et al 2015). Effective control and management of chronic illnesses require continuous, patient-centred and long-term care (Joo 2014).…”